Benzinga | Jan 27, 2022 04:15PM EST

ResMed Q2 Adj. EPS $1.47 Misses $1.52 Estimate, Sales $894.90M Miss $935.25M Estimate

ResMed (NYSE:RMD) reported quarterly earnings of $1.47 per share which missed the analyst consensus estimate of $1.52 by 3.29 percent. This is a 4.26 percent increase over earnings of $1.41 per share from the same period last year. The company reported quarterly sales of $894.90 million which missed the analyst consensus estimate of $935.25 million by 4.31 percent. This is a 11.86 percent increase over sales of $800.01 million the same period last year.